|
|
||||||||



* Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, Ludwig-Maximilians-Universität München, D-80336 München, Germany;
Medizinische Poliklinik, Ludwig-Maximilians-Universität München, D-80336 München, Germany; and
Klinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität München, D-80337 München
3Correspondence: Max von Pettenkofer-Institut, Ludwig-Maximilians-Universität München, Pettenkoferstrasse 9a, D-80336 München, Germany. E-mail: Autenrieth{at}m3401.mpk.med.uni-muenchen.de
Enteropathogenic Yersinia bacteria trigger the production of the
proinflammatory chemokine IL-8, an important chemokine for the
recruitment of polymorphonuclear leukocytes (PMN).
Yersinia is resistant to phagocytosis by PMN, and the
recruitment of these cells is thought to be part of a pathogenic
strategy of Yersinia to establish infection by allowing
the pathogen to gain access to, and disseminate within, host tissue. We
report here that Yersinia expressing the outer membrane
protein invasin triggers IL-8 production in epithelial cells. The 195
carboxyl-terminal amino acids of invasin when linked to latex beads are
sufficient to trigger IL-8 production. By means of IL-8 promoter
reporter gene assays and electrophoretic mobility shift assay
experiments, the minimal optimal region of the IL-8 promoter responsive
to invasin was identified and invasin-responsive control elements were
characterized. Invasin-induced activation of the IL-8 promoter was
found to be mediated through a previously identified NF-
B element.
This NF-
B binding site preferentially binds Rel p65-p65 homodimers
as well as some p50-p65 heterodimers in response to stimulation by
invasin. Invasin-induced NF-
B activation correlated with degradation
of I
B
and the inhibition of NF-
B by specific inhibitors of
I
B activation blocked invasin-induced IL-8 secretion.
Invasin-triggered IL-8 production does not depend on invasin-triggered
uptake of bacteria, and is independent of a functional PI3-kinase. This
report is the first to demonstrate the molecular basis of IL-8
production triggered by enteropathogenic bacteria. Together, these data
elucidate the possible early pathomechanisms operating in
Yersinia infection and may have implications for the
design of novel therapeutics directed against this
enteropathogen.Schulte, R., Grassl, G. A., Preger, S., Fessele,
S., Jacobi, C. A., Schaller, M., Nelson, P. J., Autenrieth,
I. B. Yersinia enterocolitica invasin protein
triggers IL-8 production in epithelial cells via activation of Rel
p65-p65 homodimers.
Key Words: bacteria chemokine transcription NF-
B
This article has been cited by other articles:
![]() |
J. S. Frick, K. Fink, F. Kahl, M. J. Niemiec, M. Quitadamo, K. Schenk, and I. B. Autenrieth Identification of Commensal Bacterial Strains That Modulate Yersinia enterocolitica and Dextran Sodium Sulfate-Induced Inflammatory Responses: Implications for the Development of Probiotics Infect. Immun., July 1, 2007; 75(7): 3490 - 3497. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. O'Kane, J. J. Boyle, D. E. Horncastle, P. T. Elkington, and J. S. Friedland Monocyte-Dependent Fibroblast CXCL8 Secretion Occurs in Tuberculosis and Limits Survival of Mycobacteria within Macrophages J. Immunol., March 15, 2007; 178(6): 3767 - 3776. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. McNally, T. Dalton, R. M. L. Ragione, K. Stapleton, G. Manning, and D. G. Newell Yersinia enterocolitica isolates of differing biotypes from humans and animals are adherent, invasive and persist in macrophages, but differ in cytokine secretion profiles in vitro. J. Med. Microbiol., December 1, 2006; 55(Pt 12): 1725 - 1734. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki, Y. Yoshikawa, H. Ashida, H. Iwai, T. Toyotome, H. Matsui, and C. Sasakawa High Vaccine Efficacy against Shigellosis of Recombinant Noninvasive Shigella Mutant That Expresses Yersinia Invasin J. Immunol., October 1, 2006; 177(7): 4709 - 4717. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. T. Buhler, C. A. Wiedig, Y. Schmid, G. A. Grassl, E. Bohn, and I. B. Autenrieth The Yersinia enterocolitica Invasin Protein Promotes Major Histocompatibility Complex Class I- and Class II-Restricted T-Cell Responses Infect. Immun., July 1, 2006; 74(7): 4322 - 4329. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Doerre, K. P. Mesires, K. M. Daley, T. McCarty, S. Knoetig, and R. B. Corley Reductions in I{kappa}B{epsilon} and Changes in NF-{kappa}B Activity during B Lymphocyte Differentiation J. Immunol., January 15, 2005; 174(2): 983 - 991. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Schmid, G. A. Grassl, O. T. Buhler, M. Skurnik, I. B. Autenrieth, and E. Bohn Yersinia enterocolitica Adhesin A Induces Production of Interleukin-8 in Epithelial Cells Infect. Immun., December 1, 2004; 72(12): 6780 - 6789. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Riess, S. G.E. Andersson, A. Lupas, M. Schaller, A. Schafer, P. Kyme, J. Martin, J.-H. Walzlein, U. Ehehalt, H. Lindroos, et al. Bartonella Adhesin A Mediates a Proangiogenic Host Cell Response J. Exp. Med., November 15, 2004; 200(10): 1267 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yoshida, A. Kumar, Y. Koyama, H. Peng, A. Arman, J. A. Boch, and P. E. Auron Interleukin 1 Activates STAT3/Nuclear Factor-{kappa}B Cross-talk via a Unique TRAF6- and p65-dependent Mechanism J. Biol. Chem., January 16, 2004; 279(3): 1768 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Haase, C. J. Kirschning, A. Sing, P. Schrottner, K. Fukase, S. Kusumoto, H. Wagner, J. Heesemann, and K. Ruckdeschel A Dominant Role of Toll-Like Receptor 4 in the Signaling of Apoptosis in Bacteria-Faced Macrophages J. Immunol., October 15, 2003; 171(8): 4294 - 4303. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Boulanger, F. Bureau, D. Melotte, J. Mainil, and P. Lekeux Increased Nuclear Factor {kappa}B Activity in Milk Cells of Mastitis-Affected Cows J Dairy Sci, April 1, 2003; 86(4): 1259 - 1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hauf and T. Chakraborty Suppression of NF-{kappa}B Activation and Proinflammatory Cytokine Expression by Shiga Toxin-Producing Escherichia coli J. Immunol., February 15, 2003; 170(4): 2074 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Mellits, J. Mullen, M. Wand, G. Armbruster, A. Patel, P. L. Connerton, M. Skelly, and I. F. Connerton Activation of the transcription factor NF-{kappa}B by Campylobacter jejuni Microbiology, September 1, 2002; 148(9): 2753 - 2763. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Grosdent, I. Maridonneau-Parini, M.-P. Sory, and G. R. Cornelis Role of Yops and Adhesins in Resistance of Yersinia enterocolitica to Phagocytosis Infect. Immun., August 1, 2002; 70(8): 4165 - 4176. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. James, D. Tang, A. Ingram, H. Ly, K. Thai, L. Cai, and J. W. Scholey Flux Through the Hexosamine Pathway Is a Determinant of Nuclear Factor {kappa}B- Dependent Promoter Activation Diabetes, April 1, 2002; 51(4): 1146 - 1156. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |